3Boulton A J. The diabetic foot: a global view[J]. Diabetes Metab Res Rev,2000,16(suppl 1):S2-S5. 被引量：1
4Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot?[J]. Diabetes Metab Res Rev,2000,16:S75-S83. 被引量：1
5Lavery L A, Armstrong D G, Harkless L B. Classification of diabetic foot wounds[J]. J Foot Ankle Surg,1996,35:528-531. 被引量：1
6Pham H, Armstrong D G, Harvey C, et al. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial[J]. Diabetes Care,2000,23:606-611. 被引量：1
7Sauseng S, Kastenbauer T, Sokol G, et al. Estimation of risk for plantar foot ulceration in diabetic patients with neuropathy[J]. Diabetes Nutr Metab,1999,12:189-193. 被引量：1
8Boykin J V Jr. The nitric oxide connection: hyperbaric oxygen therapy, becaplermin, and diabetic ulcer management[J]. Adv Skin Wound Care,2000,13:169-174. 被引量：1
9Holstein P E, Sorensen S. Limb salvage experience in a multidisciplinary diabetic foot unit[J]. Diabetes Care,1999,22:B97-B103. 被引量：1
10Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia[J]. Circulation, 1998,97:1114-1123. 被引量：1
